FOUNDERS & LEADERSHIP TEAM

Jeff Karp, Ph.D.
CO-FOUNDER & Member of the Scientific Advisory Board

Dr. Jeff Karp is a co‐founder of Alivio Therapeutics and is a Professor at Brigham and Women’s Hospital, Harvard Medical School. He has published more than 100 peer‐reviewed papers, has given over 200 national and international ...


Robert Langer, Sc.D.
CO-FOUNDER, Member of the Scientific Advisory Board & Board of Directors

Dr. Robert Langer is a co-founder of Alivio Therapeutics and is known for his groundbreaking discoveries in the fields of polymer chemistry, controlled drug delivery, and tissue engineering. He is the David H. Koch Institute Professor at the Massachusetts Institute of Technology...


Ivana Magovcevic‐Liebisch, Ph.D., J.D.
Member of the Board of Directors

Dr. Ivana Magovcevic-Liebisch is Executive Vice President and Chief Business Officer of Ipsen. She was previously Senior Vice President and Head of Global Business Development at Teva Pharmaceuticals. In this capacity, Ivana was responsible for the execution of transactions identified by Teva’s R&D, Global Franchises ...


Eric Elenko, Ph.D.
CO-FOUNDER & Member of the Board of Directors

Dr. Eric Elenko is a co-founder  of Alivio Therapeutics and the Chief Innovation Officer at PureTech Health. Dr. Elenko has led the development of a number of programs, including Akili Interactive Labs, Gelesis, Karuna Pharmaceuticals and Sonde Health...


Greg Zugates, Ph.D.
vice president of research and development

Dr. Zugates is the Vice President of Research and Development for Alivio Therapeutics. He joins Alivio after spending the last 10 years at Arsenal Medical, a medical device company in Watertown, MA. During this time, he has been a lead inventor in developing Arsenal's biodegradable ... 
 


AleksHeadshot.jpg

ALEKS RADOVIC-MORENO, PH.D.
CO-FOUNDER

Dr. Radovic-Moreno is a co-founder of Alivio Therapeutics and a Senior Vice President at PureTech Health. He is also a co-founder of Vor Biopharma, an immuno-oncology company which completed a $42M Series A financing in February 2019. He was previously a Research Scientist at the biotech startup Exicure (formerly AuraSense Therapeutics), where he was a lead inventor of the company's core immunotherapy ...